June 4th 2021
CPH set to expand in $300M Latin American CBD market
March 17th 2021
Revenue generating BDA sets its sights on US market
December 21st 2020
Creso Pharma’s CBD for pets secures regulatory approval in Latin America
December 15th 2020
How Creso Pharma could benefit from TGA down-scheduling of CBD
December 7th 2020
Positive regulatory ramifications for CPH from US Marijuana Act
November 30th 2020
Creso Pharma poised to cash in on CBD regulatory changes
November 26th 2020
Changes to OTC cannabis sales just around the corner
Connect with us
Subscribe for updates on our small cap, ASX listed biotech portfolio.
Thanks for subscribing!
